Dr Piers Daubeney is Reader in Paediatric Cardiology at NHLI, Imperial College London and Consultant Paediatric and Fetal Cardiologist at the Royal Brompton Hospital, Chelsea and Westminster Hospital and 3 district hospitals in the South-East.
He trained at Oxford and St Thomas' Hospitals with postgraduate training at the Wessex Cardiovascular Centre in Southampton, Royal Children's Hospital, Melbourne and the Hospital for Sick Children, Toronto.
Dr Daubeney has a research team and particular interests in the epidemiology and management of congenital heart disease, childhood cardiomyopathy, and drug studies in paediatric heart disease. He has jointly founded the following ongoing international multi-centre studies:
- UK and Ireland Study of Pulmonary Atresia with Intact Ventricular Septum
- National Australian Childhood Cardiomyopathy Study
- UK, Ireland and Sweden Study of Total Anomalous Pulmonary Venous Connection
- UK, Ireland and Sweden Study of Pulmonary Vein Stenosis.
He is also interested in the mechanisms of congenital heart disease and in particular connexin expression. He participates in a number of paediatric multi-centre drug trials in congenital heart disease.
Dr Daubeney has published widely in the field of congenital heart disease and his textbook ‘Diagnosis and Management of Adult Congenital Heart Disease' jointly edited with Professors Gatzoulis and Webb, is now in its third edition having been translated into several different languages.
Dr Daubeney is the lead clinician for paediatric cardiomyopathy at the Royal Brompton Hospital and has an active research programme. He welcomes postgraduate research fellows intending to attain higher qualifications.
et al., 2021, Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study, Esc Heart Failure, ISSN:2055-5822
et al., 2021, Left ventricular noncompaction in pediatric population: could cardiovascular magnetic resonance derived fractal analysis aid diagnosis?, Journal of Cardiovascular Magnetic Resonance, Vol:23, ISSN:1097-6647
et al., 2021, Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease, Plos Genetics, Vol:17, ISSN:1553-7404
et al., 2021, The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy., Eur J Prev Cardiol
et al., 2021, Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study, Europace, Vol:23, ISSN:1099-5129, Pages:400-408